Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance publication, a study has found. The research, which will be presented to delegates at the ...

Are you facing challenges in quickly bringing new healthtech products to market? The NHS is a large and complex system and ...

12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (review of TA834) [ID6280] Technology appraisal guidance 12 February 2025 Abaloparatide for treating ...

We use tools such as Google Analytics, Hotjar, Google Optimize and Loop11 to help us anonymously measure how you use our websites. This allows us to make improvements based on our users' needs.

The London School of Economics and Political Science (LSE) have joined forces with NICE to offer a unique solution - the Executive MSc in Healthcare Decision-Making.

We have also today published a new discussion aid to support shared decision making about HRT, focusing on the key risks and benefits to consider. The guideline clarifies that whilst HRT has some ...

To find NICE guidance on related topics, including guidance in development, see the NICE topic page on menopause. For full details of the evidence and the guideline committee's discussions, see the ...

The November 2024 version of NICE's guideline on menopause updates and replaces the previous version published in November 2015. New evidence reviewed included information on endometrial cancer, ...

Your organisation needs to be registered as a stakeholder before we can accept comments. Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your ...

Suggested remit: To appraise the clinical and cost effectiveness of talquetamab within its marketing authorisation for treating relapsed or refractory multiple myeloma after 3 treatments.